Impact of omalizumab on pollen-induced seasonal allergic rhinitis: An observational study in clinical practice

Int Forum Allergy Rhinol. 2021 Nov;11(11):1588-1591. doi: 10.1002/alr.22827. Epub 2021 May 28.

Authors

Affiliations

¹ Department of Otorhinolaryngology, Showa University School of Medicine, Tokyo, Japan.
² Department of Otorhinolaryngology, Fujigaoka hospital, Yokohama, Kanagawa, Japan.
³ Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
⁴ Department of Dermatology, Showa University School of Medicine, Tokyo, Japan.

PMID: 34047460
DOI: 10.1002/alr.22827

No abstract available

Keywords: omalizumab; pollen; seasonal allergic rhinitis.

Publication types

Observational Study

MeSH terms

Anti-Allergic Agents* / therapeutic use
Humans
Omalizumab / therapeutic use
Pollen
Rhinitis, Allergic, Seasonal* / drug therapy
Rhinitis, Allergic, Seasonal* / epidemiology

Substances

Anti-Allergic Agents
Omalizumab